Ibrutinib intermediate

Ibrutinib intermediate is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase, that is important in B cells. It is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia

2380-63-4:

Ibrutinib intermediate

Specifications:

Intermediate CAS No API/End Use Status Purity
4-Aminopyrazolo[3,4-d]pyrimidine 2380-63-4 Ibrutinib Commercial 99.30%